Skip to content
    ShangBay Capital logo

    ShangBay Capital

    Palo Alto, California, United StatesFounded 2015

    ShangBay Capital is a venture capital firm based in Palo Alto, California, focused on early-stage investments in medical devices, biopharma, and healthcare technology companies addressing unmet clinical needs. Founded in 2015 by William Dai, the firm has raised nearly $200 million in total across three funds and invested in over 50 portfolio companies.

    67% of their portfolio is in Healthcare. Their most common stage is series-a (44% of deals). Average disclosed round size is $32.6M (across 38 rounds with reported amounts).

    Find people at ShangBay Capital on Goldilocks AI

    Portfolio

    30

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    William Dai

    William Dai

    Founding Managing Partner

    Chaucer Shen

    Chaucer Shen

    Managing Partner

    Erik T. Engelson

    Erik T. Engelson

    Venture Partner

    MW

    Michael Wallace

    Venture Partner

    Cindy Costello

    Cindy Costello

    Director of Finance & Administration

    JD

    John Dai

    Associate

    OS

    Olivia Sinkula

    Associate

    AR

    Anna Roberts

    Analyst

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    39 investments
    CompanyRoundAmountDate
    SoundHealth logoSoundHealthSeries A—Jan 2026
    Nervonik logoNervonikSeries A$13MMar 2025
    Petal Surgical logoPetal SurgicalSeries A$10MJan 2025
    Nervonik logoNervonikSeries A$13MJan 2025
    FLUID BIOMED logoFLUID BIOMEDSeries A$27MDec 2024
    Inquis Medical logoInquis MedicalSeries B$40MNov 2024
    Venova Medical logoVenova MedicalSeries B$30MSep 2024
    Avation Medical logoAvation MedicalSeries C$22MFeb 2024
    FLUID BIOMED logoFLUID BIOMEDSeries A$27MJan 2024
    LLaplace Interventional Inc.Series B$12.9MJul 2023
    LLaplace Interventional Inc.Unknown$12.9MJul 2023
    Noah Medical logoNoah MedicalSeries B$150MApr 2023
    Luminopia logoLuminopiaSeries A$16MJan 2023
    NNoahmedSeries B$150MJan 2023
    FLUID BIOMED logoFLUID BIOMEDSeed$4.7MAug 2021
    IGGENIX logoIGGENIXSeries A$25MJul 2021
    EMBOLINE logoEMBOLINESeries D$55MMay 2021
    SetPoint Medical logoSetPoint MedicalSeries D$64MJan 2021
    Aqua Medical logoAqua MedicalSeries A$8.2MSep 2020
    OrthoFX logoOrthoFXSeries A$13MJul 2020
    MMEDITRINASeries A$10MJun 2020
    Zeto logoZetoSeries A$7.3MMar 2020
    ZAP SURGICAL logoZAP SURGICALGrowth$81MJan 2020
    Tioga Medical logoTioga MedicalSeries A$15MApr 2019
    Atia Vision logoAtia VisionSeries D$20MJan 2019
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026